Citadel Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$472M Buy
1,930,976
+1,146,074
+146% +$267M 0.08% 193
2025
Q4
$162M Sell
784,902
-545,257
-41% -$108M 0.02% 585
2025
Q3
$247M Buy
1,330,159
+772,718
+139% +$132M 0.04% 391
2025
Q2
$85.1M Sell
557,441
-106,579
-16% -$16.4M 0.01% 868
2025
Q1
$110M Sell
664,020
-1,201,182
-64% -$188M 0.02% 636
2024
Q4
$270M Buy
1,865,202
+1,207,406
+184% +$187M 0.05% 293
2024
Q3
$107M Sell
657,796
-797,335
-55% -$127M 0.02% 660
2024
Q2
$213M Buy
1,455,131
+853,507
+142% +$127M 0.04% 326
2024
Q1
$95.2M Buy
601,624
+533,850
+788% +$85M 0.02% 728
2023
Q4
$10.6M Sell
67,774
-389,642
-85% -$59.7M ﹤0.01% 2762
2023
Q3
$71.2M Sell
457,416
-1,774,854
-80% -$293M 0.02% 824
2023
Q2
$369M Buy
2,232,270
+557,451
+33% +$90M 0.08% 136
2023
Q1
$260M Buy
1,674,819
+1,424,288
+569% +$230M 0.06% 230
2022
Q4
$44.3M Buy
250,531
+218,146
+674% +$37.7M 0.01% 1223
2022
Q3
$5.29M Sell
32,385
-314,421
-91% -$53.2M ﹤0.01% 3764
2022
Q2
$61.6M Sell
346,806
-731,210
-68% -$130M 0.02% 866
2022
Q1
$191M Buy
1,078,016
+926,572
+612% +$158M 0.04% 361
2021
Q4
$25.9M Sell
151,444
-463,026
-75% -$75.8M 0.01% 1740
2021
Q3
$99.2M Buy
614,470
+107,420
+21% +$18.3M 0.02% 662
2021
Q2
$83.5M Buy
507,050
+336,214
+197% +$55.7M 0.02% 777
2021
Q1
$28.1M Sell
170,836
-1,049,897
-86% -$170M 0.01% 1587
2020
Q4
$192M Buy
1,220,733
+613,815
+101% +$90.6M 0.05% 272
2020
Q3
$90.4M Buy
606,918
+69,458
+13% +$10.3M 0.03% 516
2020
Q2
$75.6M Sell
537,460
-253,364
-32% -$36.9M 0.03% 544
2020
Q1
$104M Sell
790,824
-2,498,735
-76% -$355M 0.05% 324
2019
Q4
$480M Buy
3,289,559
+2,192,485
+200% +$297M 0.21% 49
2019
Q3
$142M Buy
1,097,074
+675,207
+160% +$89M 0.07% 252
2019
Q2
$58.8M Sell
421,867
-1,824,137
-81% -$252M 0.03% 643
2019
Q1
$314M Buy
2,246,004
+1,448,890
+182% +$194M 0.16% 72
2018
Q4
$103M Buy
797,114
+587,666
+281% +$82M 0.06% 312
2018
Q3
$28.9M Sell
209,448
-162,572
-44% -$21.6M 0.01% 1107
2018
Q2
$45.1M Sell
372,020
-495,056
-57% -$61.8M 0.02% 767
2018
Q1
$111M Sell
867,076
-74,418
-8% -$10.1M 0.06% 285
2017
Q4
$132M Buy
941,494
+389,810
+71% +$54.3M 0.08% 235
2017
Q3
$71.7M Buy
+551,684
New +$73.1M 0.06% 373
2017
Q1
Sell
-29,121
Closed -$3.48M 7760
2016
Q4
$3.35M Sell
29,121
-273,224
-90% -$31.6M ﹤0.01% 2387
2016
Q3
$35.7M Sell
302,345
-1,687,036
-85% -$205M 0.04% 557
2016
Q2
$241M Buy
1,989,381
+769,699
+63% +$87.5M 0.27% 37
2016
Q1
$132M Buy
1,219,682
+1,138,227
+1,397% +$118M 0.17% 83
2015
Q4
$8.37M Sell
81,455
-1,102,506
-93% -$111M 0.01% 1414
2015
Q3
$111M Buy
1,183,961
+717,620
+154% +$69.4M 0.11% 182
2015
Q2
$45.5M Buy
+466,341
New +$46.7M 0.04% 550
2015
Q1
Sell
-247,615
Closed -$25.2M 8688
2014
Q4
$25.9M Buy
247,615
+94,063
+61% +$9.91M 0.03% 794
2014
Q3
$16.4M Buy
153,552
+85,718
+126% +$8.89M 0.02% 1033
2014
Q2
$7.1M Sell
67,834
-541,407
-89% -$54.7M 0.01% 1546
2014
Q1
$59.8M Buy
609,241
+324,625
+114% +$30.1M 0.07% 332
2013
Q4
$26.1M Buy
284,616
+105,884
+59% +$9.76M 0.03% 654
2013
Q3
$15.5M Sell
178,732
-78,736
-31% -$7.06M 0.02% 842
2013
Q2
$22.1M Buy
+257,468
New +$21.8M 0.04% 607

Other funds holding JNJ

Citadel Advisors's JNJ Position: Q1 2026 in Review

Citadel Advisors increased its Johnson & Johnson (JNJ) stake by 146% in Q1 2026, buying an estimated $267M and bringing the position to 1,930,976 shares worth $472M. The position accounts for 0.08% of the portfolio, ranked #193.

Citadel Advisors first reported a position in JNJ in Q2 2013 and has held it in 49 quarters since. The position peaked at $480M in Q4 2019. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Citadel Advisors held 1,930,976 shares of Johnson & Johnson worth $472M as of Q1 2026.
  • Citadel Advisors bought 1,146,074 Johnson & Johnson shares in Q1 2026, an estimated $267M.
  • Johnson & Johnson made up 0.08% of Citadel Advisors's portfolio in Q1 2026, its #193 holding.
  • Citadel Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Johnson & Johnson position peaked at $480M in Q4 2019.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.